Chemoinformaics analysis of Proanthocyanidin A2
| Molecular Weight | 576.51 | nRot | 2 |
| Heavy Atom Molecular Weight | 552.318 | nRig | 37 |
| Exact Molecular Weight | 576.127 | nRing | 7 |
| Solubility: LogS | -4.018 | nHRing | 3 |
| Solubility: LogP | 2.627 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 4 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 24 |
| nHA | 12 | APOL | 75.727 |
| nHD | 9 | BPOL | 29.285 |
| QED | 0.158 |
| Synth | 5.361 |
| Natural Product Likeliness | 2.154 |
| NR-PPAR-gamma | 0.383 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.053 |
| Pgp-sub | 0.032 |
| HIA | 0.472 |
| CACO-2 | -6.798 |
| MDCK | 0.0000055 |
| BBB | 0.002 |
| PPB | 0.911676 |
| VDSS | 0.372 |
| FU | 0.0658928 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.12 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.616 |
| CYP2c9-sub | 0.83 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.137 |
| CYP3a4-sub | 0.504 |
| CL | 10.197 |
| T12 | 0.562 |
| hERG | 0.033 |
| Ames | 0.467 |
| ROA | 0.645 |
| SkinSen | 0.948 |
| Carcinogencity | 0.486 |
| EI | 0.904 |
| Respiratory | 0.047 |
| NR-Aromatase | 0.482 |
| Antiviral | Yes |
| Prediction | 0.754319 |